Thank you: Pharma & Life Sciences Get Together Ticino – novità regolatorie e fiscali (IT)

Last week we had the pleasure to host the first Pharma & Life Sciences get together in Ticino since 2017 in collaboration with Farma Industria Ticino.

During the event focusing mainly on regulatory and tax topics, we introduced the latest changes in the industry incl. our white paper on a game changing new pharma regulatory rules for non EU/EEA companies selling drugs in the EU, read more here.

Many thanks to all the participants who shared extremely valuable inputs and ideas.

Continue reading Thank you: Pharma & Life Sciences Get Together Ticino – novità regolatorie e fiscali (IT)

Pharma & Life Sciences Get Together Ticino – novità regolatorie e fiscali (IT)

Siamo lieti di invitarvi al nostro evento “Pharma & Life Science Get Together Ticino” nato dalla collaborazione tra PwC e Farma Industria Ticino (FIT) per presentarvi alcune novità in ambito regolatorio e fiscale di rilevanza per le società del settore farmaceutico.

In particolare durante questo evento che si terrà il 4 aprile a Villa Sassa, vi parleremo dei seguenti argomenti di attualità:

Continue reading Pharma & Life Sciences Get Together Ticino – novità regolatorie e fiscali (IT)

PwC Virtual Global ITX Health Industry Convention

Dear all,

Thank you for your interest in this year’s Global Virtual ITX Health Industry Convention. This event will be held online on Wednesday, 9 November 2022, from 15:00 to 17:00 CET.

Just like at last year’s successful event, we will be discussing current developments, innovations and challenges that are set to have a major impact on the pharmaceutical, healthcare and life science industries – with a heavy focus on indirect tax. Speakers from our various different territories will be on hand to share their expertise and country-specific views, while further sector specialists will be giving keynote speeches with further insights into strategic and industry developments.

Continue reading PwC Virtual Global ITX Health Industry Convention

The impact of Brexit on Pharma, Life Science and MedTech companies – A PwC Pharma & Life Sciences Webinar

Dear pharma & life sciences colleagues

Brexit is coming closer every day with many aspects still unclear which makes it hard for you to prepare for it.

We’re excited to take a closer look at the current status quo and the impact of Brexit on indirect taxes, movement of goods and trade for Pharma, Life Sciences and MedTech Companies.

Continue reading The impact of Brexit on Pharma, Life Science and MedTech companies – A PwC Pharma & Life Sciences Webinar

PwC’s Pharma & Life Sciences Hot Topics 2020

The year 2020 has seen a lot of development in the way we do business such as new regulations and smarter solutions to solve old and new challenges. PwC has identified the following hot topics for Pharma & Life Sciences which need our special attention:

Continue reading PwC’s Pharma & Life Sciences Hot Topics 2020

Pharma & Life Sciences: 4 cutting edge digital tax & regulatory solutions

Discover PwC’s four cutting edge digital tax & regulatory solutions and how they can add value to your business, help you complying with new laws, stay up to date with upcoming changes in legislation and regulatory.

Continue reading Pharma & Life Sciences: 4 cutting edge digital tax & regulatory solutions

PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA

Dear pharma & life sciences colleagues,

It was a pleasure to welcome you to our webinar: PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA.

Attached below you can download the presentation.

Continue reading PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA

PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA – Thursday 28. May 2020, 10:30 CEST

As the COVID-19 situation develops, tax and regulatory specialists within the pharmaceutical & life sciences industry are increasingly facing complex challenges. Efficient and pragmatic solutions have to be realised, with fewer resources, in line with the changing local legislation.

The exchange of information is the best practice in this industry to support and inspire you in your daily business.

Continue reading PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA – Thursday 28. May 2020, 10:30 CEST

Cutting Edge Digital Solution – Pharma & Life Sciences Regulatory Radar

Dear all

I hope you had a relaxing summer time.

Do you face troubles in order to be up to date with all the required legislation changes in various countries in the Regulatory Pharma & Life Sciences field AND combine it with your supply chain and tax strategy?

I am happy to inform you that we have recently launched our Pharma & Life Sciences Regulatory Radar, to strive to assist you in that regard.

Continue reading Cutting Edge Digital Solution – Pharma & Life Sciences Regulatory Radar